ArticleDrug design, development and therapy2016

miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.

Xian-ye Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.